370 related articles for article (PubMed ID: 30230171)
21. Comprehensive imaging manifestations of tuberous sclerosis.
Manoukian SB; Kowal DJ
AJR Am J Roentgenol; 2015 May; 204(5):933-43. PubMed ID: 25905927
[TBL] [Abstract][Full Text] [Related]
22. New developments in the neurobiology of the tuberous sclerosis complex.
Crino PB; Henske EP
Neurology; 1999 Oct; 53(7):1384-90. PubMed ID: 10534239
[TBL] [Abstract][Full Text] [Related]
23. Different MRI-defined tuber types in tuberous sclerosis complex: Quantitative evaluation and association with disease manifestations.
Jesmanas S; Norvainytė K; Gleiznienė R; Šimoliūnienė R; Endzinienė M
Brain Dev; 2018 Mar; 40(3):196-204. PubMed ID: 29258718
[TBL] [Abstract][Full Text] [Related]
24. Tuberous sclerosis complex presenting as convulsive status epilepticus followed by hypoxic cerebropathy: A case report.
Liu X; Zhang Y; Hao Y; Chen Y; Chen C
Medicine (Baltimore); 2019 May; 98(19):e15545. PubMed ID: 31083211
[TBL] [Abstract][Full Text] [Related]
25. Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy.
Curatolo P
Pediatr Neurol; 2015 Mar; 52(3):281-9. PubMed ID: 25591831
[TBL] [Abstract][Full Text] [Related]
26. Solitary subependymal giant cell astrocytoma: Case report and review of the literature.
Corlette L; Reid A; Roberts-Thomson S; Christie M; Gaillard F
J Clin Neurosci; 2020 Dec; 82(Pt A):26-28. PubMed ID: 33317733
[TBL] [Abstract][Full Text] [Related]
27. Brain lesions in tuberous sclerosis complex. Review.
Grajkowska W; Kotulska K; Jurkiewicz E; Matyja E
Folia Neuropathol; 2010; 48(3):139-49. PubMed ID: 20924998
[TBL] [Abstract][Full Text] [Related]
28. Stochastic model of Tsc1 lesions in mouse brain.
Prabhakar S; Goto J; Zhang X; Sena-Esteves M; Bronson R; Brockmann J; Gianni D; Wojtkiewicz GR; Chen JW; Stemmer-Rachamimov A; Kwiatkowski DJ; Breakefield XO
PLoS One; 2013; 8(5):e64224. PubMed ID: 23696872
[TBL] [Abstract][Full Text] [Related]
29. Isolated cortical tuber in an infant with genetically confirmed tuberous sclerosis complex 1 presenting with symptomatic West syndrome.
Miyata H; Fushimi S; Ota Y; Vinters HV; Adachi K; Nanba E; Akiyama T
Neuropathology; 2021 Feb; 41(1):58-64. PubMed ID: 33181865
[TBL] [Abstract][Full Text] [Related]
30. Tuberous sclerosis and epilepsy: role of astrocytes.
Wong M; Crino PB
Glia; 2012 Aug; 60(8):1244-50. PubMed ID: 22438024
[TBL] [Abstract][Full Text] [Related]
31. Minimal mosaicism, maximal phenotype: Discordance between clinical and molecular findings in two patients with tuberous sclerosis.
Byers HM; Jensen DM; Glass IA; Bennett JT
Am J Med Genet C Semin Med Genet; 2018 Sep; 178(3):374-378. PubMed ID: 30260069
[TBL] [Abstract][Full Text] [Related]
32. Neurological and neuropsychiatric aspects of tuberous sclerosis complex.
Curatolo P; Moavero R; de Vries PJ
Lancet Neurol; 2015 Jul; 14(7):733-45. PubMed ID: 26067126
[TBL] [Abstract][Full Text] [Related]
33. Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients.
Kotulska K; Borkowska J; Roszkowski M; Mandera M; Daszkiewicz P; Drabik K; Jurkiewicz E; Larysz-Brysz M; Nowak K; Grajkowska W; Domańska-Pakieła D; Jóźwiak S
Pediatr Neurol; 2014 Apr; 50(4):307-12. PubMed ID: 24507694
[TBL] [Abstract][Full Text] [Related]
34. Subependymal giant cell tumors in tuberous sclerosis complex.
Goh S; Butler W; Thiele EA
Neurology; 2004 Oct; 63(8):1457-61. PubMed ID: 15505165
[TBL] [Abstract][Full Text] [Related]
35. The genomic landscape of tuberous sclerosis complex.
Martin KR; Zhou W; Bowman MJ; Shih J; Au KS; Dittenhafer-Reed KE; Sisson KA; Koeman J; Weisenberger DJ; Cottingham SL; DeRoos ST; Devinsky O; Winn ME; Cherniack AD; Shen H; Northrup H; Krueger DA; MacKeigan JP
Nat Commun; 2017 Jun; 8():15816. PubMed ID: 28643795
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.
Franz DN; Belousova E; Sparagana S; Bebin EM; Frost M; Kuperman R; Witt O; Kohrman MH; Flamini JR; Wu JY; Curatolo P; de Vries PJ; Whittemore VH; Thiele EA; Ford JP; Shah G; Cauwel H; Lebwohl D; Sahmoud T; Jozwiak S
Lancet; 2013 Jan; 381(9861):125-32. PubMed ID: 23158522
[TBL] [Abstract][Full Text] [Related]
37. Neuropathology of tuberous sclerosis.
Mizuguchi M; Takashima S
Brain Dev; 2001 Nov; 23(7):508-15. PubMed ID: 11701246
[TBL] [Abstract][Full Text] [Related]
38. Mutational analysis of TSC1 and TSC2 genes in Tuberous Sclerosis Complex patients from Greece.
Avgeris S; Fostira F; Vagena A; Ninios Y; Delimitsou A; Vodicka R; Vrtel R; Youroukos S; Stravopodis DJ; Vlassi M; Astrinidis A; Yannoukakos D; Voutsinas GE
Sci Rep; 2017 Dec; 7(1):16697. PubMed ID: 29196670
[TBL] [Abstract][Full Text] [Related]
39. [Tuberous sclerosis without mental impairment, diagnosed in adulthood].
Timotin L; Sarrot-Reynauld F; Lantuejoul S; Pasquier B; Massot C; Ashraf A; Borgel F
Rev Med Interne; 2005 Jun; 26(6):511-3. PubMed ID: 15936480
[TBL] [Abstract][Full Text] [Related]
40. Wide spectrum of clinical manifestations in children with tuberous sclerosis complex--follow-up of 20 children.
Mettin RR; Merkenschlager A; Bernhard MK; Elix H; Hirsch W; Kiess W; Syrbe S
Brain Dev; 2014 Apr; 36(4):306-14. PubMed ID: 23751858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
